Human donor bone marrow cells induce in vitro "suppressor T cells" that functionally suppress autologous B cells

Human Immunology

Volumn 64, Issue 1, 2003, Pages 21-30

  Carreno, Manuel R ^a   Fuller, Laphalle ^a   Mathew, James M ^a   Ciancio, Gaetano ^a   Burke, George W ^a   Esquenazi, Violet ^a,b   Ricordi, Camillo ^a   Tzakis, Andreas G ^a   Miller, Joshua ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bone marrow cells; PRA; T suppressor cells; Transplantation

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; HLA ANTIGEN; MONOCLONAL ANTIBODY;

ANTIGEN ANTIBODY REACTION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; KIDNEY ALLOGRAFT; LYMPHOCYTE DEPLETION; NONHUMAN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SPLEEN CELL; SUPPRESSOR CELL;

BONE MARROW; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL CULTURE TECHNIQUES; HUMANS; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0037242494     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(02)00774-7     Document Type: Article

References (41)

1. Monaco AP, Clark AW, Wood ML, Sahyoun AI, Codish SD, Brown RW: Possible active enhancement of a human cadaver renal allograft with antilymphocyte serum (ALS) and donor bone marrow: case report of an initial attempt. Surgery 79:384, 1976.
2. Barber WH, Mankin JA, Laskow DA, Deierhoi MH, Julian BA, Curtis JJ, Diethelm AG: Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 51:70, 1991.
3. Sayegh MH, Fine NA, Smith JL, Rennke HG, Milford EL, Tilney NL: Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med 114:954, 1991.
4. Fontes P, Rao AS, Demetris AJ, Zeevi A, Trucco M, Carroll P, Rybka W, Rudert WA, Ricordi C, Dodson F, Shapiro R, Tzakis A, Todo S, Abu-Elmagd K, Jordan M, Fung JJ, Starzl TE: Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet 344:151, 1994.
5. Opelz G, Terasaki PI: Dominant effect of transfusions on kidney graft survival. Transplantation 29:153, 1980.
6. Fuller TC, Delmonico FL, Cosimi B, Huggins CE, King M, Russell PS: Impact of blood transfusion on renal transplantation. Ann Surg 187:211, 1978.
7. Salvatierra O Jr, Melzer J, Potter D, Garovoy M, Vincenti F, Amend WJ, Husing R, Hopper S, Feduska NJ: A seven-year experience with donor-specific blood transfusions. Results and considerations for maximum efficacy. Transplantation 40:654, 1985.
8. Light JA, Metz S, Oddenino K, Strong DM, Simonis T, Biggers JA, Fernandez-Bueno C: Donor-specific transfusion with diminished sensitization. Transplantation 34: 352, 1982.
9. Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, Ildstad S, Ramos H, Todo S, Tzakis A, Fung JJ, Nalesnik M, Zeevi A, Rudert WA, Kocova M: Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance [Review]. Hepatology 17:1127, 1993.
10. Starzl TE, Demetris AJ, Rao AS, Thomson AW, Trucco M, Murase N: Migratory nonparenchymal cells after organ allotransplantation: with particular reference to chimerism and the liver. Prog Liver Dis 12:191, 1994.
11. Spitzer TR, Delmonico F, Tolkoff-Rubin N, McAfee S, Sackstein R, Saidman S, Colby C, Sykes M, Sachs DH, Cosimi AB: Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 68:480, 1999.
12. Wood K, Sachs DH: Chimerism and transplantation tolerance: cause and effect. Immunol Today 17:584, 1996.
13. SivaSai KS, Alevy YG, Duffy BF, Brennan DC, Singer GG, Shenoy S, Lowell JA, Howard T, Mohanakumar T: Peripheral blood microchimerism in human liver and renal transplant recipients: rejection despite donor-specific chimerism. Transplantation 64:427, 1997.
14. SivaSai KS, Jendrisak M, Duffy BF, Phelan D, Ravenscraft M, Howard T, Mohanakumar T: Chimerism in peripheral blood of sensitized patients waiting for renal transplantation: clinical implications. Transplantation 69:538, 2000.
15. Ciancio G, Miller J, Garcia-Morales RO, Carreno M, Burke GW 3rd, Roth D, Kupin W, Tzakis AG, Ricordi C, Rosen A, Fuller L, Esquenazi V: Six-year clinical effect of donor bone marrow infusions in renal transplant patients. Transplantation 71:827, 2001.
16. Garcia-Morales R, Carreno M, Mathew J, Zucker K, Cirocco R, Ciancio G, Burke G, Roth D, Temple D, Rosen A, Fuller L, Esquenazi V, Karatzas T, Ricordi C, Tzakis A, Miller J: The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients. J Clin Invest 99:1118, 1997.
17. Garcia-Morales R, Carreno M, Mathew J, Cirocco R, Zucker K, Ciancio G, Burke G, Roth D, Temple D, Fuller L, Esquenazi V, Eskind L, Kenyon NS, Ricordi C, Tzakis A, Miller J: Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients. Transplantation 65:956, 1998.
18. Miller J, Mathew J, Garcia-Morales R, Zucker KE, Carreno M, Jin Y, Fuller L, Burke GW, Ciancio G, Tzakis AG, Ricordi C, Olson L, Rosen A, Roth D, Esquenazi V: The human bone marrow as an immunoregulatory organ. Transplantation 68:1079, 1999.
19. Emara MA, Mozes MF: Cytotoxic T-cell role in renal allograft rejection and regulation. Renal allograft infiltrating cytotoxic T-cell line with suppressor-inducer function. Hum Immunol 42:161, 1995.
20. Baker RJ, Hernandez-Fuentes MP, Brookes PA, Chaudhry AN, Lechler RI: The role of the allograft in the induction of donor-specific T cell hyporesponsiveness. Transplantation 72:480, 2001.
21. Ciubotariu R, Vasilescu R, Ho E, Cinti P, Cancedda C, Poll L, Late M, Liu Z, Berloco P, Cortesini R, Suciu-Foca Cortesini N: Detection of T suppressor cells in patients with organ allografts. Hum Immunol 62:15, 2001.
22. Harris PE, Cortesini R, Suciu-Foca N: Indirect allorecognition in solid organ transplantation. Rev Immunogenet 1:297, 1999.
23. Mathew JM, Marsh JW, Susskind B, Mohanakumar T: Analysis of T cell responses in liver allograft recipients. Evidence for deletion of donor-specific cytotoxic T cells in the peripheral circulation. J Clin Invest 91:900, 1993.
24. Jin Y, Fuller L, Esquenazi V, Blomberg BB, Rosen A, Tzakis AG, Ricordi C, Miller J: Bone marrow cells inhibit the generation of autologous EBV-specific CTL. Hum Immunol 61:538, 2000.
25. Mathew JM, Carreno M, Fuller L, Ricordi C, Tzakis A, Esquenazi V, Miller J: Modulatory effects of human donor bone marrow cells on allogeneic cellular immune responses. Transplantation 63:686, 1997.
26. Mathew JM, Fuller L, Carreno M, Garcia-Morales R, Burke GW 3rd, Ricordi C, Esquenazi V, Tzakis AG, Miller J: Involvement of multiple subpopulations of human bone marrow cells in the regulation of allogeneic cellular immune responses. Transplantation 70:1752, 2000.
27. Mathew JM, Garcia-Morales R, Fuller L, Rosen A, Ciancio G, Burke GW, Carreno M, Temple D, Tzakis AG, Ricordi C, Miller J, Esquenazi V: Donor bone marrow-derived chimeric cells present in renal transplant recipients infused with donor marrow. I. Potent regulators of recipient antidonor immune responses. Transplantation 70:1675, 2000.
28. Gatenby PA, Kansas GS, Xian CY, Evans RL, Engleman EG: Dissection of immunoregulatory subpopulations of T lymphocytes within the helper and suppressor sublineages in man. J Immunol 129:1997, 1982.
29. Kansas GS, Wood GS, Fishwild DM, Engleman EG: Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-leu-8. J Immunol 134:2995, 1985.
30. Thomas Y, Rogozinski L, Irigoyen OH, Friedman SM, Kung PC, Goldstein G, Chess L: Functional analysis of human T cell subsets defined by monoclonal antibodies. IV. Induction of suppressor cells within the OKT4+ population. J Exp Med 154:459, 1981.
31. Murakawa Y, Strober W, James SP: Monoclonal antibody against the human peripheral lymph node homing receptor homologue (Leu 8) inhibits B cell differentiation but not B cell proliferation. J Immunol 146:40, 1991.
32. Buelow R, Mercier I, Glanville L, Regan J, Ellingson L, Janda G, Claas F, Colombe B, Gelder F, Grosse-Wilde H, Orosz C, Westhoff U, Voegeler U, Monteiro F, Pouletty P: Detection of panel-reactive anti-HLA class I antibodies by enzyme-linked immunosorbent assay or lymphocytotoxicity. Results of a blinded, controlled multicenter study. Hum Immunol 44:1, 1995.
33. Ciancio G, Burke GW, Roth D, Miller J: Tacrolimus and mycophenolate mofetil regimens in transplantation: benefits and pitfalls. BioDrugs 11:395, 1999.
34. Jin Y, Fuller L, Wei Y, Blomberg BB, Miller J, Esquenazi V: Bone marrow cells promote TH2 polarization and inhibit virus-specific CTL generation. Hum Immunol 61: 1233, 2000.
35. Jin Y, Fuller L, Carreno M, Esquenazi V, Blomberg BB, Wei YT, Ciancio G, Burke GW, Tzakis A, Ricordi C, Miller J: Functional and phenotypic properties of peripheral T cells anergized by autologous CD3(+) depleted bone marrow cells. Hum Immunol 63:567, 2002.
36. McKenna RM, Takemoto SK, Terasaki PI: Anti-HLA antibodies after solid organ transplantation. Transplantation 69:319, 2000.
37. Russell PS, Chase CM, Colvin RB: Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice. Transplantation 64:1531, 1997.
38. Najafian N, Salama AD, Fedoseyeva EV, Benichou G, Sayegh MH: Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients. J Am Soc Nephrol 13:252, 2002.
39. Holthe JE, Gasser M, Womer K, Najafian N, Dong V, Samsonov DV, Geehan CS, Chandraker A, Sayegh MH, Waaga AM: Regulatory functions of alloreactive Th2 clones in human renal transplant recipients. Kidney Int 62:627, 2002.
40. Gould DS, Auchincloss H Jr: Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol Today 20:77, 1999.
41. Auchincloss H Jr, Lee R, Shea S, Markowitz JS, Grusby MJ, Glimcher LH: The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci USA 90:3373, 1993.